ABEONA THERAPEUTICS INC (ABEO) Stock Income Statement
NASDAQ:ABEO - Nasdaq - US00289Y2063 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 3.50M | 1.41M | 3.00M | |||
| Operating Expenses | 69.61M | 64.21M | 51.70M | 46.67M | 60.37M | |||
| Research and Development | 37.09M | 34.36M | 31.09M | 28.97M | 34.33M | |||
| Selling, General, and Administrative Expenses | 32.51M | 29.85M | 19.00M | 17.26M | 22.80M | |||
| Operating Income | -69.61M | -64.21M | -48.20M | -45.26M | -57.37M | |||
| Interest Income/Expense | 459.00K | 38.00K | 1.70M | -310.00K | -3.60M | |||
| Other Income/Expense | 24.96M | 439.00K | -8.75M | 11.52M | -13.48M | |||
| Non Recurring Items | N/A | 0.00 | 1.06M | -5.66M | -30.71M | |||
| Income Before Taxes | -44.19M | -63.73M | -54.19M | -39.70M | -84.94M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -44.19M | -63.73M | -54.19M | -43.48M | -84.94M | |||
| EBITDA | -66.61M | -61.30M | -45.00M | -42.17M | -54.12M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.92 | -1.55 | -2.53 | -5.53 | -21.57 | |||
| Non GAAP EPS | -0.82 | -1.74 | -2.71 | -5.53 | -15.75 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -1548.23% | -3083.69% | -2831.33% | |||
| Operating Profit Margin | N/A | N/A | -1377.14% | -3209.93% | -1912.33% | |||
All data in USD